Market Overview:
Brain
Aneurysm is an abnormal dilation of arteries in the brain which finally results
in the weakening of inner muscular layer of the blood vessel wall. Over time,
blood flow within the artery starts pushing the thin portion of the wall and
ruptures it. The resultant bleeding due to ruptured artery in the brain is
called subarachnoid hemorrhage (SAH). This kind of hemorrhage may lead to coma,
stroke, and/or death. There are number of factors that contribute to the
occurrence of brain aneurysms, such as cigarette smoking, injury or trauma,
blood infections, and many others. Individuals harboring a brain aneurysm can
be diagnosed by various techniques, such as Computed Tomography (CT) scan,
Computed Tomography Angiogram (CTA) scan, Magnetic Resonance Angiography (MRA),
cerebral angiogram, and many others.
The global Brain Aneurysm Treatment Market Share is expected to grow
at a compound annual rate of 5.4% during the forecast period between 2017
and 2023.
Market
Research Future (MRFR) asserts in its report that the global market is
influenced by various key factors. This includes, the increasing and widespread
prevalence of brain aneurysms, rising occurrence of high blood pressure, rapid
advancements in surgical techniques, and increasing funding by the government
and related bodies in the healthcare sector. Also, the presence of brain
aneurysm in the family is another key driver of the market.
Market
Research Future (MRFR) asserts in its report that the global market is
influenced by various key factors. This includes, the increasing and widespread
prevalence of brain aneurysms, rising occurrence of high blood pressure, rapid
advancements in surgical techniques, and increasing funding by the government
and related bodies in the healthcare sector. Also, the presence of brain
aneurysm in the family is another key driver of the market.
Competitive Landscape:
·
Codman & Shurtleff
·
Medtronic Plc
·
Orsan Medical Technologies
·
Head Sense Medical
·
InfraScan
·
MicroPort Scientific Corporation
·
Raumedic AG
·
HaiWeiKang
·
Johnson & Johnson
·
Spiegelberg GmbH
Market Segmentation:
·
The brain aneurysm treatment market
segmentation is based in terms of condition, type, and end-user.
·
By type, the market divides into medication
and surgery.
·
The surgery segment narrows down further
into endovascular coiling, surgical clipping, flow diverter, and others. The
flow diverter segment breaks down into silk flow diverter (SILK), pipeline
embolization device, and surpass flow diverter (SURPASS).
·
The medication segment comprises calcium
channel blockers, anti-seizure medications, antacids, antiemetics, analgesics,
antihypertensives, stool softeners, and others.
·
By end-user, the market includes clinics,
hospital, and others.
·
By condition, the market divides into
ruptured and unruptured aneurysm.
Regional Analysis:
The global brain aneurysm
treatment market is geographically segmented into major regions like Asia
Pacific, Europe, the Americas, and the Middle East & Africa.
The Americas hold the
dominant share of the global aneurysm treatment market and is expected to grow
significantly in the forthcoming years. The growth of the region is attributed
to the increasing prevalence of brain aneurysm.
The European region holds
the second largest share of the market for brain aneurysm. The region’s growth
is proliferated by the support provided by the government for research and
development and for the improvement of reimbursement policies in healthcare.
Also, cerebrovascular conditions are also seemingly prevalent in this region,
which is also aiding the growth herein.
The Asia Pacific region is
positioned as one of the key players in the global brain aneurysm treatment
landscape. It is expected to hold the potential to be the fastest growing
region among the mentioned names. The surging growth and expansion of the
region can be owed to the massive patient population and the ameliorating
healthcare technology.
The Middle East &
Africa regions holds the least share in the brain aneurysm treatment market
owing to the lack of proper availability of medical facilities. However, the
decent growth market in this region is driven by some of the most advancing
countries in the Middle East, including Saudi Arabia, the UAE, and Kuwait.
While, the African region is expected to garner moderate growth rate.
NOTE : Our team of researchers are studying
Covid19 and its impact on various industry verticals and wherever required we
will be considering covid19 footprints for a better analysis of markets and
industries. Cordially get in touch for more details.
No comments:
Post a Comment